The Seal of Excellence certifies the high-quality of the CLARITY proposal aimed at enhancing its data coverage, artificial intelligence approaches and analytics tools for drug discovery. Barcelona, July 11th, 2019….
Read More
Chemotargets was presenting CLARITYⓇ v3.0 and the new features of v4.0 at three international audience conferences: 17-20th June 2019 – World Pharma Week, Boston (US) https://www.pharmaweek.com/ 26-28th June 2019 –…
Visit us at stand number P132 Chemotargets will be First time Exhibitor at the in-cosmetics Global event, which will take place on the 2nd-4th April 2019 in Paris (France). We…
Join us at booth number 4210 Chemotargets will participate at the Society of Toxicology Annual meeting (SOT2019) in Baltimore, MD, March 10-14, 2019. We will be present Chemotargets CLARITYⓇ, the…
Updates on data and models, and a new analytics module to navigate FAERS data This new version includes as improvements to previous release. Updates of data and models processed: DATA…
The collaboration aims to enhance CDER’s safety assessments of human pharmaceuticals, supporting the FDA’s mission of protecting public health. Barcelona / Washington D.C., USA: The Food and Drug Administration’s Center…
Chemotargets has been invited to speak at the Chem-Bio Informatics Society (CBI) Annual Meeting: “Drug Discovery and Development Pioneered by Data-Driven Research"” which takes place in Tokyo, Oct. 3-5, 2017....
Read More
Barcelona, May 2017 – Prous Institute for Biomedical Research announced today that it has made a strategic investment in Chemotargets SL. Founded by Dr. Jordi Mestres as a spin-off of...
Read More
